Mitomics, QDx Ink Development, Marketing Pact

QDx will develop, market, and process the QPredict Prostate Mitomic Test, which will be based on Mitomics' flagship mitochondrial DNA-based prostate cancer diagnostic.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories